Skip to content

Clinical trials

Schizophrenia, Treatment-Resistant trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia, Treatment-Resistant Country / region: United Kingdom Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20161
20171
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Daniel Benjamin1
H. Lundbeck A/S1
King's College London1
Mersey Care NHS Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia, Treatment-Resistant4
Schizophrenia2
Adenoviridae Infections1
Anxiety Disorders1
Arrhythmias, Cardiac1
Autistic Disorder1
Bipolar Disorder1
Bradycardia1
Central Nervous System Infections1
Cytomegalovirus Retinitis1

Trials

Showing 26 to 4 of 4. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.